Corcept Therapeutics
CORT
#2462
Rank
NZ$12.72 B
Marketcap
NZ$116.30
Share price
-2.09%
Change (1 day)
-14.20%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): NZ$2.66

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ$2.74. In 2025 the company made an earnings per share (EPS) of NZ$1.72 a decrease over its 2024 EPS that were of NZ$2.47.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$2.6654.64%
2025NZ$1.72-30.37%
2024NZ$2.47
2022NZ$1.74-2.06%
2021NZ$1.775.43%
2020NZ$1.6810.84%
2019NZ$1.5227.69%
2018NZ$1.19-42.48%
2017NZ$2.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21 345.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.60 250.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.30-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.47 1,959.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.82-33.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.26 201.33%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ-$0.24-108.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.03656-101.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16-106.00%๐Ÿ‡บ๐Ÿ‡ธ USA